Showing 201 - 220 results of 2,543 for search '"Amyloid beta"', query time: 0.50s Refine Results
  1. 201

    Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment by Takuya Ataka, Noriyuki Kimura, Naoki Kaneko, Teruaki Masuda, Yosuke Takeuchi, Kenichi Yabuuchi, Takeshi Mizukami, Tsukasa Takeuchi, Temmei Ito, Hideaki Tasai, Takehiko Miyagawa, Shunya Hanai, Shinichi Iwamoto, Etsuro Matsubara

    Published 2024-10-01
    “…Abstract INTRODUCTION Previous studies have examined the predictive accuracy of plasma amyloid beta (Aβ) biomarkers in clinical cohorts. However, their accuracy for predicting amyloid‐positive patients in community‐based cohorts is unclear. …”
    Get full text
    Article
  2. 202

    Nicotinamide Ameliorates Amyloid Beta-Induced Oxidative Stress-Mediated Neuroinflammation and Neurodegeneration in Adult Mouse Brain by Inayat Ur Rehman, Riaz Ahmad, Ibrahim Khan, Hyeon Jin Lee, Jungsung Park, Rahat Ullah, Myeong Jun Choi, Hee Young Kang, Myeong Ok Kim

    Published 2021-04-01
    “…Alzheimer’s disease (AD) is the most predominant age-related neurodegenerative disease, pathologically characterized by the accumulation of aggregates of amyloid beta Aβ<sub>1–42</sub> and tau hyperphosphorylation in the brain. …”
    Get full text
    Article
  3. 203
  4. 204

    The Impact of Amyloid-Beta Positivity with 18F-Florbetaben PET on Neuropsychological Aspects in Parkinson’s Disease Dementia by Seunghee Na, Hyeonseok Jeong, Jong-Sik Park, Yong-An Chung, In-Uk Song

    Published 2020-09-01
    “…Four patients (17.4%) showed significant amyloid burden. Patients with amyloid-beta showed poorer performance in executive function and more severe neuropsychiatric symptoms than those without amyloid-beta. …”
    Get full text
    Article
  5. 205

    Higher Level of Mismatch in 4 Carriers for Amyloid-Beta Peptide Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid by Jonathan Vogelgsang, Ruth Vukovich, Dirk Wedekind, Jens Wiltfang

    Published 2019-05-01
    “…Even though there is a causal correlation between apolipoprotein E ( APOE ) genotype and amyloid-beta (Aβ), the determination of APOE is currently not supported by national or international guidelines. …”
    Get full text
    Article
  6. 206

    Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala by Maria-Luisa Appleman, Jeremy L. Thomas, Alison R. Weiss, Benjamin I. Nilaver, Rita Cervera-Juanes, Steven G. Kohama, Henryk F. Urbanski, Henryk F. Urbanski, Henryk F. Urbanski

    Published 2024-01-01
    “…BackgroundAmyloid beta (Aβ) plaque density was examined in the amygdala of rhesus macaques, to elucidate the influence of age, diet and hormonal environment.MethodsLuminex technology was used to measure cerebrospinal fluid (CSF) concentrations of Aβ40 and Aβ42 across three decades, while immunohistochemistry was used to examine Aβ plaque density in the amygdala.ResultsAβ40 was found to be the predominant isoform of Aβ in the CSF, but neither Aβ40 or Aβ42 concentrations showed an age-related change, and the ratio of Aβ42 to Aβ40 showed only a marginal increase. …”
    Get full text
    Article
  7. 207
  8. 208
  9. 209

    Do radiomics or diffusion-tensor images provide additional information to predict brain amyloid-beta positivity? by Sungyang Jo, Hyunna Lee, Hyung-Ji Kim, Chong Hyun Suh, Sang Joon Kim, Yoojin Lee, Jee Hoon Roh, Jae-Hong Lee

    Published 2023-06-01
    “…The study population included 72 patients with MCI in the amyloid-beta-negative group and 114 patients with MCI in the amyloid-beta-positive group. …”
    Get full text
    Article
  10. 210
  11. 211

    Neurotoxicity of Amyloid Beta and its Association with other Biomarkers in Pathogenesis of Alzheimer’s Disease: A Narrative Review by Ram Prakash Sah, CS Vidya, Pratibha Pereira, Shubha Jayaram, Anshu Kumar Yadav, P Sujatha

    Published 2024-10-01
    “…Amyloid beta (Aβ) deposition in the brain is regarded as an early toxic effect in the aetiopathogenesis of Alzheimer’s Disease (AD). …”
    Get full text
    Article
  12. 212
  13. 213

    Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta by Michalina Hebda, Marek Bajda, Anna Więckowska, Natalia Szałaj, Anna Pasieka, Dawid Panek, Justyna Godyń, Tomasz Wichur, Damijan Knez, Stanislav Gobec, Barbara Malawska

    Published 2016-03-01
    “…Cholinesterases and amyloid beta are one of the major biological targets in the search for a new and efficacious treatment of Alzheimer’s disease. …”
    Get full text
    Article
  14. 214

    Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity. by Panchika Prangkio, Erik C Yusko, David Sept, Jerry Yang, Michael Mayer

    Published 2012-01-01
    “…Aggregates of amyloid-beta (Aβ) peptides are thought to be involved in the development of Alzheimer's disease because they can change synaptic plasticity and induce neuronal cell death by inflammation, oxidative damage, and transmembrane pore formation. …”
    Get full text
    Article
  15. 215
  16. 216
  17. 217

    Ginsenoside F1 Protects the Brain against Amyloid Beta-Induced Toxicity by Regulating IDE and NEP by Yee-Jin Yun, Bong-Hwan Park, Jingang Hou, Jung-Pyo Oh, Jin-Hee Han, Sun-Chang Kim

    Published 2022-01-01
    “…Although the effects of ginsenosides on amyloid beta (Aβ) aggregation in the brain are known, the role of ginsenoside F1 remains unclear. …”
    Get full text
    Article
  18. 218

    Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta₂₅₋₃₅ via the Autophagy Pathway. by Pengjuan Xu, Zhigui Li, Hui Wang, Xiaochen Zhang, Zhuo Yang

    Published 2015-01-01
    “…Evidence shows that an abnormal deposition of amyloid beta-peptide25-35 (Aβ25-35) was the primary cause of the pathogenesis of Alzheimer's disease (AD). …”
    Get full text
    Article
  19. 219
  20. 220